biomedicine

So reducing donations to the University is not likely to have a huge impact on research (at least in my field - biomedicine).

The patient is not a document - multimodal foundation models for biomedicine.

The onus is on the biomedicine industry to demonstrate it's capable of producing anything of societal importance because so far it's largely failed to deliver.

The result, at least in biomedicine, is an increase in the size of research groups, and very protracted postdoctoral periods.

Some of these patterns of epistemic contestation resemble those in non-musical domains (such as biomedicine).

Slightly off-topic but related: currently I'm in a research environment (biomedicine) where a lot of AI is used.

This is largely solved in biomedicine by funders (not journals) and regulatory bodies requiring that human subjects research data be stored with NIH.

In biomedicine, we’re always looking for therapies that approximate the level of precision control available in software.

You can also see serious KR use in certain domains like biomedicine.

This is one area where biomedicine is way ahead of computer science.

Great experiment, but I wonder how usefull can be a bunch of people playing a game without any knowledge of biomedicine.

Cuts seem to be directed at biomedicine, health and social studies.

In biomedicine, Amgen could reproduce only 6/53 “landmark” preclinical cancer papers and Bayer reported widespread failures.

However, in biomedicine, when a new prof has "startup" funds, these are often linked to their contributions to teaching and "service", i.e.

I have a PhD in Pharmaceutical Science / Biomedicine.